PyInvesting

Market research

300558.SHE Betta Pharmaceuticals Co., Ltd

SHE CNY Healthcare

Latest close

41.62 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
20B
P/E ratio
75.14
Analyst target
58.14
Dividend yield
0.3%
Beta
0.62

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Betta Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.

From a valuation standpoint, the stock is 133.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 22.5.

Betta Pharmaceuticals Co., Ltd's total revenue rose by 16.8% to $363M since the same quarter in the previous year.

Its net income has increased by 186.7% to $93M since the same quarter in the previous year.

Finally, its free cash flow fell by 68.0% to $8M since the same quarter in the previous year.

Based on the above factors, Betta Pharmaceuticals Co., Ltd gets an overall score of 2/5.